From: Troponin I levels in permanent atrial fibrillation—impact of rate control and exercise testing
Treatment | Hs-TnI at rest, ng/L | Hs-TnT at rest, ng/L | Decrease in hs-TnI associated with treatment relative to baseline level, ng/L | Decrease in hs-TnT associated with treatment relative to baseline level, ng/L | Decrease in hs-TnI associated with treatment relative to baseline level, % | Decrease in hs-TnT associated with treatment relative to baseline level, % |
---|---|---|---|---|---|---|
Baseline | 5.2 (3.8, 8.5) | 10.0 (7.0, 13.0) | ||||
Diltiazem | 4.5 (3.3, 5.9) | 9.0 (7.0, 12.0) | 0.14 (0.04, 0.30) | 0.14 (0.0, 0.23) | 14 % | 14 % |
Verapamil | 4.1 (2.8, 5.6) | 8.0 (6.0, 11.0) | 0.24 (0.09, 0.41)* | 0.18 (0.05, 0.25) | 24 % | 18 % |
Metoprolol | 4.1 (2.7, 6.2) | 8.0 (6.0, 10.5) | 0.18 (0.02, 0.33) | 0.14 (0.0, 0.25) | 18 % | 14 % |
Carvedilol | 4.5 (3.0, 6.0) | 8.0 (6.0, 12.0) | 0.18 (0.01, 0.32) | 0.13 (0.0, 0.20) | 18 % | 13 % |